Routine use of next generation sequencing (NGS) for preimplantation genetic diagnostics (PGD) of blastomeres obtained from embryos on day 3 in fresh IVF cycles.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014070118202N2

Enrollment

Registered

2014-07-10

Start date

2014-08-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility. Female infertility, unspecified

Interventions

Next Generation Sequencing Preimplantation Genetic Diagnosis embryo selection.

Diagnosis

Next Generation Sequencing Preimplantation Genetic Diagnosis embryo selection

Eligibility

Sex/Gender

All

Age

31 Years to 38 Years

Inclusion criteria

Inclusion criteria: Incusion: 1. Patients undergoing in vitro fertilization in Invicta Fertility and Reproductive Centre s. z o.o. in time frame from 08.2014 to 01.2015 Exclusion: 1. Patients who did not received embryo transfer in first cycle 2. Lack of data/results according to 5 verifications (that means 6-8 week after embryo transfer)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pregnancy rate. Timepoint: on 6 weeks and 1-3 days. Method of measurement: clinical poregnancy (as ultrasound fetal heartbeat detection).	—

Secondary

Measure	Time frame
Implantation rate. Timepoint: 7 day after tansfer. Method of measurement: blood serum beta-HCG concentration.	—

Countries

Poland

Contacts

Public ContactJudyta Zabielska

Invicta Gdansk

judyta.zabielska@invicta.pl00485858 58 810

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026